Tumour-targeted delivery of therapeutic nanoparticles
NanoCapture is a translational biomedical research project based at the Pharmacy Department of the Ludwig-Maximilians University of Munich, Germany. Supported by the GO-Bio program of the German Federal Government (BMBF), we aim to significantly improve the selectivity of drug delivery to solid tumours.
NanoCapture is a multidisciplinary team with experts in chemistry, in vivo biology and oncology.
DR. JULIA THORN-SESHOLD
Julia brings a background in tumour biology, immunology and molecular biology, and experience in conducting clinical trials. She is responsible for the science and development program in NanoCapture.
DR. ANNABEL KITOWSKI
Chemistry and Analytics
Annabel holds a PhD in Medical Biochemistry. She is responsible for translating chemistry from the bench to in vivo applications, for ADME/PK, and the strategic direction of the project.
in vivo assays
Constanze is our technical assistant with extensive experience in oncology research and in vivo models. She runs our in vivo assays, biochemical assays, and manages the lab.
DR. OLIVER THORN-SESHOLD
Oliver is the inventor of the NanoCapture concept and won the 2015 Innovationsakademie competition. Oliver leads a medicinal chemistry research group at the LMU Pharmacy Department.